Nuclear Inclusion Bodies of Mutant and Wild-Type P53 in Cancer: a Hallmark Of
View metadata, citation and similarbrought papersCORE to atyou core.ac.uk by provided by Lirias Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodeling by p53 aggregation. Nuclear inclusion bodies of p53 in cancer Frederik De Smet1,2,3,4,#, Mirian Saiz Rubio1,2,#, Daphne Hompes5, Evelyne Naus1,2, Greet De Baets1,2, Tobias Langenberg1,2, Mark S. Hipp6, Bert Houben1,2, Filip Claes1,2, Sarah Charbonneau3, Javier Delgado Blanco1,2, Stephane Plaisance7, Shakti Ramkissoon3,8,9, Lori Ramkissoon3, Colinda Simons10, Piet van den Brandt10, Matty Weijenberg10, Manon Van England11, Sandrina Lambrechts12, Frederic Amant12,13, André D’Hoore5, Keith L. Ligon3,4,8,9,14, Xavier Sagaert15, Joost Schymkowitz 1,2,* and Frederic Rousseau 1,2,*. 1. The Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, B-3000, Belgium 2. VIB Center for Brain and Disease, Leuven, B-3000, Belgium 3. Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana- Farber Cancer Institute, Boston, MA 02215, USA 4. The Broad Institute, Cambridge, MA 02142, USA Article 5. Department of Abdominal Surgery, University Hospitals Gasthuisberg, Leuven, B-3000, Belgium 6. Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany 7. Nucleomics core, Flanders Institute for Biotechnology (VIB), Leuven, B-3000, Belgium 8. Department of Pathology, Division of Neuropathology, Brigham and Women’s Hospital and Children’s Hospital Boston, Boston, MA 02215, USA 9. Department of Pathology, Harvard Medical School, Boston, MA 02215, USA 10. Department of Epidemiology – GROW School for Oncology and Developmental Biology, Maastricht University, the Netherlands.
[Show full text]